<p>The expression of CD133 (red) and B7H1 (green) in HT29 cells (A) (Bar = 20 μm), and expression of EpCAM (blue), CD133 (red) and B7H1 (green) in colorectal cancer tissues (B) (Bar = 50 μm) were determined by immunofluorescence staining. The nucleuses were stained with DAPI (grey). The rectangle area in the image is enlarged (C) and shows a typical co-expression of CD133 and B7H1 (indicated with arrows). It is shown a representative rectal moderately differentiated adenocarcinoma, T3N0M0.</p
Colon cancer stem cells (CSC) can be identified with AC133, an antibody that detects an epitope on C...
Objective: CD133 has recently been reported as a marker of cancer stem-like cells in colorectal canc...
BACKGROUND: "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsibl...
<p>##: data was obtained from 7 cases of B7H1 expressed on cancer cells in T3M0N0 stage.</p><p>$$: d...
<p>The expression of CD133 (red), E-cadherin (green) (A) or CD133 (red) and vimentin (green) (B) or ...
Aims: The CD133 antigen has been identified as a putative stem cell marker in colorectal cancer t...
Cancer stem cells (CSCs) can invade and metastasize by epithelial-to-mesenchymal transition (EMT). H...
Summary: Background/Objective: CD133 is currently considered the most robust surface marker for col...
The cancer stem cell model suggests that only a rare subpopulation, known as cancer stem cells (CSC)...
The CD133 molecule has been proposed as a surface marker of cancer stem cells in several human malig...
<p>(A and B): Detection of EPHB2 (green), ERBB3 (red) and KI-67 (grey) by co-immunofluorescence in t...
<p>(A)Schematic of CD133<sup>+</sup> and CD133<sup>-/lo</sup> tumor cells sorting from dissociated c...
Experimental data indicate that colorectal cancer cells with CD133 expression exhibit enhanced tumor...
Background: Colorectal cancer (CRC) is one of the most common malignancies in the world. The cancer ...
CD133 is a membrane molecule that has been, controversially, reported as a CSC marker in colorectal ...
Colon cancer stem cells (CSC) can be identified with AC133, an antibody that detects an epitope on C...
Objective: CD133 has recently been reported as a marker of cancer stem-like cells in colorectal canc...
BACKGROUND: "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsibl...
<p>##: data was obtained from 7 cases of B7H1 expressed on cancer cells in T3M0N0 stage.</p><p>$$: d...
<p>The expression of CD133 (red), E-cadherin (green) (A) or CD133 (red) and vimentin (green) (B) or ...
Aims: The CD133 antigen has been identified as a putative stem cell marker in colorectal cancer t...
Cancer stem cells (CSCs) can invade and metastasize by epithelial-to-mesenchymal transition (EMT). H...
Summary: Background/Objective: CD133 is currently considered the most robust surface marker for col...
The cancer stem cell model suggests that only a rare subpopulation, known as cancer stem cells (CSC)...
The CD133 molecule has been proposed as a surface marker of cancer stem cells in several human malig...
<p>(A and B): Detection of EPHB2 (green), ERBB3 (red) and KI-67 (grey) by co-immunofluorescence in t...
<p>(A)Schematic of CD133<sup>+</sup> and CD133<sup>-/lo</sup> tumor cells sorting from dissociated c...
Experimental data indicate that colorectal cancer cells with CD133 expression exhibit enhanced tumor...
Background: Colorectal cancer (CRC) is one of the most common malignancies in the world. The cancer ...
CD133 is a membrane molecule that has been, controversially, reported as a CSC marker in colorectal ...
Colon cancer stem cells (CSC) can be identified with AC133, an antibody that detects an epitope on C...
Objective: CD133 has recently been reported as a marker of cancer stem-like cells in colorectal canc...
BACKGROUND: "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsibl...